Anika Therapeutics Inc/ US0352551081 /
2024-04-24 10:00:00 PM | Chg. +0.1100 | Volume | Bid10:07:25 PM | Ask10:07:25 PM | High | Low |
---|---|---|---|---|---|---|
25.9000USD | +0.43% | 31,400 Turnover: 465,803.4652 |
10.4100Bid Size: 200 | 28.5500Ask Size: 100 | 26.1400 | 25.7200 |
GlobeNewswire
02-27
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
GlobeNewswire
02-13
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Ar...
GlobeNewswire
2023-11-28
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyalur...
GlobeNewswire
2023-11-02
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on G...
GlobeNewswire
2023-10-10
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
GlobeNewswire
2023-09-19
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System duri...
GlobeNewswire
2023-08-17
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based ...
GlobeNewswire
2022-03-23
Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS...
GlobeNewswire
2022-02-08
Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022